Stay updated on Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial

Sign up to get notified when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's Locations section was reorganized to enumerate site locations by state (Arizona, California, Colorado, Florida, Georgia, Illinois, Kentucky, Michigan, Mississippi, Missouri, Nebraska, New Mexico, North Carolina, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington) and a new Revision: v3.3.3 tag appears; individual state-location entries were removed, and the HHS Vulnerability Disclosure link was deleted.
    Difference
    1%
    Check dated 2025-12-23T00:34:52.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; it appears to be a minor site version update with no changes to the study details or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T11:43:15.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Publications section now clarifies that entries are automatically filled from PubMed and may not pertain to the study; the revision label updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T11:06:53.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The government funding/operating status notice at the top of the page has been removed. Core study details such as the NCT number, title, design, and locations remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-17T06:09:34.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The new screenshot shows only minor UI/layout tweaks and no changes to core study details such as the title, eligibility criteria, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T00:47:05.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    3%
    Check dated 2025-10-05T07:16:50.000Z thumbnail image

Stay in the know with updates to Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.